Showing results (371-380 of 413) with videos related to

Sort By:
Pageof 42
The Journal of Infectious Diseases|September 9, 2020
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, MassachusettsVivek Naranbhai, Christina C Chang, Wilfredo F Garcia Beltran, et al.
JAMA Network Open|August 10, 2022
Durability of Heterologous and Homologous COVID-19 Vaccine BoostsC Sabrina Tan, Ai-Ris Y Collier, Jingyou Yu, et al.
The Journal of Infection|May 11, 2025
Impact of co-infection with SARS-CoV-2 and other respiratory viruses on illness: Pooled analyses of 11 COVID-19 cohortsMarieke L A de Hoog, Emma S E M Hauser-van Westrhenen, Angelique M A M Winkel, et al.
Emerging Infectious Diseases|May 20, 2015
Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatusJ W M van der Linden, M C Arendrup, A Warris, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spikePei Tong, Avneesh Gautam, Ian Windsor, et al.
Cell|November 10, 2020
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody ProductionYuezhou Chen, Adam Zuiani, Stephanie Fischinger, et al.
Cell Host & Microbe|November 19, 2024
A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in miceJames Brett Case, Shilpa Sanapala, Carly Dillen, et al.
Immunity|August 20, 2022
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responsesJeroen M J Tas, Ja-Hyun Koo, Ying-Cing Lin, et al.
NPJ Vaccines|February 14, 2023
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in miceEtsuro Nanishi, Francesco Borriello, Hyuk-Soo Seo, et al.
Annals of the New York Academy of Sciences|November 16, 2022
Antibodies as drugs-a Keystone Symposia reportJennifer Cable, Erica Ollmann Saphire, Adrian C Hayday, et al.
Pageof 42